Neuron Bio offers preclinical R&D services for the biomedicine, toxicological and agro-food areas, developing tailor-made projects through the use of in vitro and in vivo models (efficacy and safety, behavior studies …) in multiple areas of study. We also have the capability to create transgenic animals for the study of any human disease.
The comprehensive offer of Neuron Bio is highly demanded by national or international companies that externalize part of their R&D projects. The final goal is to assist the client in the evaluation of its products under development with the aim of a later successful market entry.
In vitro e in silico services
Automated in vitro assays for a quick and efficient evaluation of functional and security properties of any compound.
Screening platform services
Zebrafish Platform
Neuron Bio has developed a range of technologies based in the use of zebrafish and rodents to boost the development process of our clients.
So, the zebrafish provides scientific evidence on the best products under development as a previous stage to their validation in mammals. Costs and development times are much more reduced in comparison with the rodent model.
One of the most important advantages of this animal model is that it is excluded from the animal testing regulation because it is not considered a vertebrate organism until 6 days after birth, thus allowing experimentation with them avoiding long bureaucratic periods related to animal testing.
Rodent Platform
As a later step to the zebrafish it is always necessary to carry out studies in mammal models. Therefore, Neuron Bio offers preclinical studies in rat and mouse model according to the client’s requirements and to recommendations and guidelines from regulatory agencies (EMA, FDA, OECD…).
Creation of genetic tools and
transgenic animals
Neuron Bio works in the creation of transgenic animals (zebrafish and mouse), in the management of colonies and in the validation of the model through behavior assays.
